← Back to headlines
S&P Upgrades Teva Pharmaceuticals Credit Rating on Financial Improvements
Credit rating agency S&P has upgraded Teva’s outlook, citing successful debt reduction efforts and a robust pharmaceutical pipeline as key drivers for improved financial stability.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
